Finance

Lists
HNSA:STO
Hansa Biopharma AB
၃၃.၃၈ SEK
-၁.၃၆%
(-၀.၄၆) 1D
အောက် ၈, GMT+၂ ၁၇:၂၉:၃၃  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
၃၃.၈၄ SEK
High
၃၄.၀၀ SEK
Low
၃၃.၁၄ SEK
Mkt. cap
၃၃၁.၅၄ ဋေ
Avg. vol.
၆.၁၁ သိန်း
Volume
၃.၃၄ သိန်း
52-wk high
၄၈.၂၂ SEK
52-wk low
၂၃.၅၂ SEK
EPS
-၇.၉၀ SEK
Shares outstanding
၁၀.၁၈ ကုဋေ
No. of employees
၁၃၁
Open
၃၃.၈၄ SEK
High
၃၄.၀၀ SEK
Low
၃၃.၁၄ SEK
Mkt. cap
၃၃၁.၅၄ ဋေ
Avg. vol.
၆.၁၁ သိန်း
Volume
၃.၃၄ သိန်း
52-wk high
၄၈.၂၂ SEK
52-wk low
၂၃.၅၂ SEK
EPS
-၇.၉၀ SEK
Shares outstanding
၁၀.၁၈ ကုဋေ
No. of employees
၁၃၁
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
Solstice Advanced Materials (SOLS) On Metropolis Settlement And Why Valuation Still Looks Debatable
Forbes
Forbes
·
ပြီးခဲ့သည့် ၃၂ မိနစ်
The S&P 500 Yields Barely 1%. Income Investors Need A New Playbook
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၁၁ မိနစ်
Hemab Therapeutics (NASDAQ:COAG) Shares Up 6% - Time to Buy?
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
Third-Quarter Earnings Season Begins Next Week and May Deliver Very Good News for the Market
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees၁၃၁
Founded၂၀၀၇
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၃.၀၈ ကုဋေ
၇.၆၀ ကုဋေ
၃.၄၆ ကုဋေ
၄.၈၁ ကုဋေ
Cost of goods sold
၂.၀၁ ကုဋေ
၂.၄၇ ကုဋေ
၁.၃၈ ကုဋေ
၂.၂၃ ကုဋေ
Cost of revenue
၂.၀၁ ကုဋေ
၂.၄၇ ကုဋေ
၁.၃၈ ကုဋေ
၂.၂၃ ကုဋေ
Research and development expenses
၇.၀၂ ကုဋေ
၇.၄၄ ကုဋေ
၅.၇၃ ကုဋေ
၆.၇၉ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၈၄ ကုဋေ
၁၀.၁၆ ကုဋေ
၁၀.၅၆ ကုဋေ
၁၁.၈၉ ကုဋေ
Operating expense
၁၆.၀၄ ကုဋေ
၁၇.၆၀ ကုဋေ
၁၆.၂၉ ကုဋေ
၁၈.၆၈ ကုဋေ
Total operating expenses
၁၈.၀၅ ကုဋေ
၂၀.၀၇ ကုဋေ
၁၇.၆၇ ကုဋေ
၂၀.၉၂ ကုဋေ
Operating income
-၁၄.၉၇ ကုဋေ
-၁၂.၄၇ ကုဋေ
-၁၄.၂၁ ကုဋေ
-၁၆.၁၁ ကုဋေ
Other non operating income
-
-
၁.၃၈ သန်း
-၃.၀၅ ကုဋေ
EBT including unusual items
-၁၄.၇၆ ကုဋေ
-၁၆.၉၅ ကုဋေ
-၁၉.၅၉ ကုဋေ
-၂၅.၉၉ ကုဋေ
EBT excluding unusual items
-၁၄.၇၆ ကုဋေ
-၁၆.၉၅ ကုဋေ
-၁၉.၅၉ ကုဋေ
-၂၅.၉၉ ကုဋေ
Income tax expense
၆.၉၃ သိန်း
၃.၉၆ သိန်း
၄.၅၃ သိန်း
၆.၇၇ သိန်း
Effective tax rate
-၀.၄၇%
-၀.၂၃%
-၀.၂၃%
-၀.၂၆%
Other operating expenses
၁.၇၉ သန်း
-၃.၄၀ သောင်း
-
၂.၈၀ သောင်း
Net income
-၁၄.၈၃ ကုဋေ
-၁၆.၉၉ ကုဋေ
-၁၉.၆၃ ကုဋေ
-၂၆.၀၅ ကုဋေ
Net profit margin
-၄၈၁.၂၉%
-၂၂၃.၅၈%
-၅၆၇.၈၉%
-၅၄၁.၇၁%
Earnings per share
-၁.၇၅
-၁.၆၂
-၁.၉၃
-၂.၂၆
Interest and investment income
၁.၀၃ ကုဋေ
-
၂.၅၅ သန်း
၃.၂၀ သန်း
Interest expense
-၁.၀၂ ကုဋေ
-၂၀.၈၁ ကုဋေ
-၂.၈၉ ကုဋေ
-၅.၈၅ ကုဋေ
Net interest expenses
၄.၉၀ သောင်း
-၂၀.၈၁ ကုဋေ
-၂.၆၃ ကုဋေ
-၅.၅၃ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁၄.၉၁ ကုဋေ
-၁၂.၄၁ ကုဋေ
-၁၄.၁၅ ကုဋေ
-၁၄.၉၄ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ